Health Justice Initiative - HJI
@HealthJusticeIn
Followers
4K
Following
7K
Media
991
Statuses
8K
Dedicated law & policy unit focusing on intersection between health rights, inequality & justice. @[email protected] [email protected]
Cape Town, South Africa
Joined June 2020
Must Read: 'A new HIV prevention jab could end AIDS – unless secrecy and greed get in the way' Via: @SpotlightNSP Link: https://t.co/retXAOGJK9
spotlightnsp.co.za
A new HIV prevention jab has the potential to bring an end to the AIDS epidemic. But a lack of ambition and unjustifiable secrecy over pricing is holding it back, argue three leading health activists.
0
6
4
The lesson from history is clear: When lifesaving HIV treatment was delayed, millions died needlessly. We cannot afford the same mistake with HIV prevention, write Fatima Hassan, Leena Menghaney, and Bellinda Nkoana. @HealthJusticeIn
https://t.co/0mcXJVchJm
1
2
4
🎧 Listen in🎧 Our HJI - @Radio702 Interview this morning on LEN-LA: 'New HIV Prevention injection shows promising results - Breakfast with Bongani Bingwa' - https://t.co/GkRkCW4IrK
https://t.co/qWaO2Xn3YS
#LENLA4ALL
#GILEAD
omny.fm
Enterprise podcasting made simple.
0
0
0
If international actors are serious about equitable access, then price transparency must be non-negotiable.
0
1
1
Must Read: 'A new HIV prevention jab could end AIDS – unless secrecy and greed get in the way' Via: @SpotlightNSP Link: https://t.co/retXAOGJK9
spotlightnsp.co.za
A new HIV prevention jab has the potential to bring an end to the AIDS epidemic. But a lack of ambition and unjustifiable secrecy over pricing is holding it back, argue three leading health activists.
0
6
4
"Imagine a new HIV prevention tool existed that could – if it reached the right people – flick the switch to prevent almost all new HIV cases across the world... @_HassanF , Leena Menghaney, and Bellinda Nkoana brilliant piece @HealthJusticeIn
https://t.co/mFFROZE10j
spotlightnsp.co.za
A new HIV prevention jab has the potential to bring an end to the AIDS epidemic. But a lack of ambition and unjustifiable secrecy over pricing is holding it back, argue three leading health activists.
0
3
5
'PRICE SECRECY' | As delegates convene at the SA AIDS Conference, they must publicly call out the demand for price secrecy from Gilead and the Global Fund for what it is: bullying. #SAAIDS05 @HealthJusticeIn
https://t.co/0mcXJVcPyU
0
1
1
Read our latest op ed here on Gilead's greed; the GFATM's worrying push to normalise price secrecy; and why SA should act differently, with urgency: Link: https://t.co/HpVyYSYBaY
@HealthJusticeIn
@sankalprehab
@HealthGAP
@JustTreatment
#ABIA
#LENLAFORALL
#STOPGILEADGREED
0
4
3
MUST READ | The lesson from history is clear: When lifesaving HIV treatment was delayed, millions died needlessly. We cannot afford the same mistake with HIV prevention, write Fatima Hassan, Leena Menghaney, and Bellinda Nkoana. @HealthJusticeIn
https://t.co/0mcXJVchJm
spotlightnsp.co.za
A new HIV prevention jab has the potential to bring an end to the AIDS epidemic. But a lack of ambition and unjustifiable secrecy over pricing is holding it back, argue three leading health activists.
1
6
7
The push to normalise secrecy, particularly when public or donor money is involved, should ring alarm bells.
1
1
1
Millions who need HIV prevention could face rationing, with health providers forced to leave the most vulnerable populations behind.
1
1
1
Just in: 📖 FAQ 2: No Borders, No Barriers, No Excuses Read our coalition's new FAQ on LEN-LA access & implications of Gilead's license for access, price transparency & affordability. 📲 https://t.co/iTv4dNfs7T WITH: @sankalprehab
@JustTreatment
@HealthGAP
#ABIA
@MSF
0
3
1
Just in: 📖 FAQ 2: No Borders, No Barriers, No Excuses Read our coalition's new FAQ on LEN-LA access & implications of Gilead's license for access, price transparency & affordability. 📲 https://t.co/iTv4dNfs7T WITH: @sankalprehab
@JustTreatment
@HealthGAP
#ABIA
@MSF
0
3
1
Access to life saving treatment should not only be for the privileged: SACFA and HJI call on the @CompComSA to re-open the investigation into Vertex, for equal, equitable access to Trikafta. #accessNotsecured Download our FAQ here. https:// https://t.co/hSKjP4J37Z
'Access for the Privileged' SA Health Advocates Demand Competition Commission Reopen Vertex Investigation 1/2 of eligible cystic fibrosis patients in public & private health sectors still cannot access life-saving drug. https://t.co/nrYT4vyiUr
@VertexSaveUs @JustTreatment
0
1
3
Access to life saving treatment should not only be for the privileged: SACFA and HJI call on the @CompComSA to re-open the investigation into Vertex, for equal, equitable access to Trikafta. #accessNotsecured Download our FAQ here. https:// https://t.co/hSKjP4J37Z
'Access for the Privileged' SA Health Advocates Demand Competition Commission Reopen Vertex Investigation 1/2 of eligible cystic fibrosis patients in public & private health sectors still cannot access life-saving drug. https://t.co/nrYT4vyiUr
@VertexSaveUs @JustTreatment
0
1
3
'Access for the Privileged' SA Health Advocates Demand Competition Commission Reopen Vertex Investigation 1/2 of eligible cystic fibrosis patients in public & private health sectors still cannot access life-saving drug. https://t.co/nrYT4vyiUr
@VertexSaveUs @JustTreatment
healthjusticeinitiative.org.za
The South African Cystic Fibrosis Association and HJI have tabled evidence with the Competition Commission of South Africa, demanding it re-open its investigation into Vertex Pharmaceuticals.
0
6
4
'Access for the Privileged' SA Health Advocates Demand Competition Commission Reopen Vertex Investigation 1/2 of eligible cystic fibrosis patients in public & private health sectors still cannot access life-saving drug. https://t.co/nrYT4vyiUr
@VertexSaveUs @JustTreatment
healthjusticeinitiative.org.za
The South African Cystic Fibrosis Association and HJI have tabled evidence with the Competition Commission of South Africa, demanding it re-open its investigation into Vertex Pharmaceuticals.
0
6
4
Secrecy was among the most powerful tools that concentrated power:
0
2
1
South African negotiators objected, labeled these unacceptable, but they ultimately remained in the contracts.
1
2
1